Please assess the completion status of the following clinical trial:

Trial Title: A Study of Avastin (Bevacizumab) in Combination With mFOLFOX-6 or FOLFOXIRI in Patients With Metastatic Colorectal Cancer.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* adult patients, \>=18 years of age;~* unresectable liver metastasis secondary to cancer of colon or rectum;~* scheduled for standard first line chemotherapy;~* ECOG performance score of 0 or 1;~* condition feasible for major abdominal surgery after first line treatment.~Exclusion Criteria:~* diagnosis of metastatic disease \>3 months prior to study entry;~* evidence of extrahepatic disease, diffuse peritoneal carcinosis or involvement of celiac lymph nodes;~* prior systemic or local treatment of metastatic disease;~* prior (neo)adjuvant chemotherapy/radiotherapy completed within 6 months prior to study entry;~* history or evidence of CNS disease unrelated to cancer.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).